Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| IL1-H82F8 | Human | Biotinylated Human IL-1RL1 / ST2 Protein, Fc,Avitag™ (MALS verified) |  |
|
|
| IL1-M5259 | Mouse | Mouse IL-1RL1 / ST2 Protein, Fc Tag |  |
|
|
| IL1-H82E9 | Human | Biotinylated Human IL-1RL1 / ST2 Protein, His,Avitag™ (MALS verified) |  |
|
|
| IL1-H5250 | Human | Human IL-1RL1 / ST2 Protein, Fc Tag |  |
|
|
| IL1-H5229 | Human | Human IL-1RL1 / ST2 Protein, His Tag (MALS verified) |  |
|
|
Loaded Human IL-1RL1, Fc Tag (Cat. No. IL1-H5250) on Protein A Biosensor, can bind with Biotinylated Human IL-33, His,Avitag (Cat. No. IL3-H82H5) an affinity constant of 1.81 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| Astegolimab | AMG-282; RG-6149; RO-7187807 | Phase 3 Clinical | Amgen Inc, F. Hoffmann-La Roche Ltd | Coronavirus Disease 2019 (COVID-19); Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
| Recombinant humanized anti-ST2 monoclonal antibody | 9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
| Melrilimab | GSK-3772847; CNTO-7160 | Phase 2 Clinical | Johnson & Johnson Innovative Medicine | Asthma | Details |
| TQC-2938 | TQC2938; TQC-2938 | Phase 1 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Asthma | Details |
| Astegolimab | AMG-282; RG-6149; RO-7187807 | Phase 3 Clinical | Amgen Inc, F. Hoffmann-La Roche Ltd | Coronavirus Disease 2019 (COVID-19); Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
| Recombinant humanized anti-ST2 monoclonal antibody | 9-MW1911; 9MW-1911; 9-MW-1911; 9MW1911 | Phase 2 Clinical | Mabwell (Shanghai) Bioscience Co Ltd | Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
| Melrilimab | GSK-3772847; CNTO-7160 | Phase 2 Clinical | Johnson & Johnson Innovative Medicine | Asthma | Details |
| TQC-2938 | TQC2938; TQC-2938 | Phase 1 Clinical | Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group | Asthma | Details |
This web search service is supported by Google Inc.
A-Z
